Guhan Pharmaceutical Group Co Ltd
000590
Company Profile
Business description
Guhan Pharmaceutical Group Co Ltd is engaged in the development and sale of products under the "Guhan Health Essence" series, as well as proprietary Chinese medicines. Its business scope includes the sale of pre-packaged health foods, foods for special medical purposes, and infant formula milk powder and other infant formula products. In addition, the company provides health consulting services and general health care services, excluding medical diagnosis and treatment activities.
Contact
No. 1 Luojinqiao
Yanfeng District Industrial Project Cluster
Hunan Province
Hengyang421001
CHNT: +86 7348239335
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
1,159
Stocks News & Analysis
stocks
Meta earnings: Strong end to 2025 as AI monetization begins to show
Investors please with latest results.
stocks
Why doesn’t the market like the earnings from this US tech giant?
Good quarter with AI demand ramping.
stocks
Our Tesla fair value increases meaningfully
Progress on Robotaxi and Optimus shows real world AI growth.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,164.80 | 78.50 | -0.85% |
| CAC 40 | 8,104.60 | 33.24 | 0.41% |
| DAX 40 | 24,468.34 | 158.88 | 0.65% |
| Dow JONES (US) | 48,972.05 | 43.55 | -0.09% |
| FTSE 100 | 10,190.24 | 18.48 | 0.18% |
| HKSE | 27,387.11 | 439.80 | -1.58% |
| NASDAQ | 23,685.12 | 172.33 | -0.72% |
| Nikkei 225 | 53,322.85 | 35.86 | -0.07% |
| NZX 50 Index | 13,423.18 | 10.31 | 0.08% |
| S&P 500 | 6,939.31 | 38.72 | -0.55% |
| S&P/ASX 200 | 8,869.10 | 54.10 | -0.61% |
| SSE Composite Index | 4,117.95 | 40.04 | -0.96% |